TransMedics Group, Inc. is a Healthcare company based in the United States. With a high-risk rating score of 31.4, TransMedics Group is revolutionizing organ transplant therapy for end-stage organ failure patients. Their Organ Care System (OCS) utilizes advanced technology to mimic near-physiologic conditions for donor organs outside of the human body, addressing the limitations of traditional cold storage methods. TransMedics Group has developed a proprietary system to preserve and deliver human organs for transplant in optimal conditions, making them a leader in ESG-focused medical technology.